173 tracked 13F filers disclose a position in ORIC as of the latest SEC 13F filings, a combined $1.4B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Nextech Invest Ltd. | $90.8M | 7.2M | —Held | Q1 2026 | |
| 2 | EcoR1 Capital, LLC | $85.2M | 6.7M | —Held | Q1 2026 | |
| 3 | BlackRock, Inc. | $75.8M | 6.0M | ▲+1.9% Added · +109K sh | Q1 2026 | |
| 4 | VIKING GLOBAL INVESTORS LP | $73.8M | 5.8M | ▼−11% Reduced · −748K sh | Q1 2026 | |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | $68.3M | 5.4M | ▲+64% Added · +2.1M sh | Q1 2026 | |
| 6 | PFIZER INC | $64.5M | 5.4M | —Held | Q3 2025 | |
| 7 | STATE STREET CORP | $53.0M | 4.9M | ▲+32% Added · +1.2M sh | Q2 2026 | |
| 8 | SR ONE CAPITAL MANAGEMENT, LP | $50.0M | 4.6M | ▲+2.2% Added · +100K sh | Q2 2026 | |
| 9 | ALKEON CAPITAL MANAGEMENT LLC | $57.1M | 4.5M | —Held | Q1 2026 | |
| 10 | Venrock Adviser, LLC | $54.7M | 4.3M | ▼−24% Reduced · −1.4M sh | Q1 2026 | |
| 11 | NEA Management Company, LLC | $52.2M | 4.1M | —Held | Q1 2026 | |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | $46.7M | 3.7M | →First observed position No prior filed position | Q1 2026 | |
| 13 | Column Group LLC | $44.9M | 3.5M | —Held | Q1 2026 | |
| 14 | Siren, L.L.C. | $32.5M | 3.0M | —Held | Q2 2026 | |
| 15 | ORBIMED ADVISORS LLC | $34.1M | 2.7M | ▼−26% Reduced · −948K sh | Q1 2026 | |
| 16 | FMR LLC | $30.8M | 2.4M | ▼−1.8% Reduced · −45K sh | Q1 2026 | |
| 17 | CITADEL ADVISORS LLC | $30.7M | 2.4M | ▼−0.5% Reduced · −12K sh | Q1 2026 | |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | $22.6M | 2.1M | ▲+14% Added · +251K sh | Q2 2026 | |
| 19 | First Turn Management, LLC | $21.8M | 2.0M | —Held | Q2 2026 | |
| 20 | Integral Health Asset Management, LLC | $20.6M | 1.9M | ▲+36% Added · +500K sh | Q2 2026 | |
| 21 | Vivo Capital, LLC | $20.0M | 1.8M | —Held | Q2 2026 | |
| 22 | MPM BioImpact LLC | $22.9M | 1.8M | ▲+0.3% Added · +5K sh | Q1 2026 | |
| 23 | Paradigm Biocapital Advisors LP | $21.6M | 1.7M | ▼−29% Reduced · −700K sh | Q1 2026 | |
| 24 | MORGAN STANLEY | $21.3M | 1.7M | ▲+41% Added · +488K sh | Q1 2026 | |
| 25 | GOLDMAN SACHS GROUP INC | $18.7M | 1.5M | ▼−24% Reduced · −464K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 10 funds opened a new position in ORIC and 25 added to an existing one, while 22 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 80 funds | $119.0B |
| REVOLUTION MEDICINES INCRVMD | 80 funds | $5.4B |
| NVIDIA CORPNVDA | 78 funds | $246.6B |
| MICROSOFT CORPMSFT | 78 funds | $166.4B |
| ELI LILLY & COLLY | 77 funds | $51.1B |
| CYTOKINETICS INCCYTK | 76 funds | $1.3B |
| BROADCOM INCAVGO | 74 funds | $98.8B |
| MICRON TECHNOLOGY INCMU | 74 funds | $22.5B |
| INTUITIVE SURGICAL INCISRG | 74 funds | $18.3B |
| COGENT BIOSCIENCES INCCOGT | 74 funds | $1.2B |
| APPLE INCAAPL | 73 funds | $183.5B |
| ALPHABET INC-CL AGOOGL | 73 funds | $94.3B |
Ranked by how many of ORIC's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | Piscitelli Dominic | Chief Financial Officer | Sell (S) | 77K | $1.1M |
| Jul 24, 2026 | Heyman Richard A. | Director | Sell (S) | 7K | $84K |
| Jul 24, 2026 | Heyman Richard A. | Director | Sell (S) | 6K | $73K |
| Jul 6, 2026 | Heyman Richard A. | Director | Sell (S) | 300 | $4K |
| Feb 24, 2026 | Piscitelli Dominic | Chief Financial Officer | Sell (S) | 52K | $703K |
| Jan 16, 2026 | Heyman Richard A. | Director | Sell (S) | 3K | $38K |
| Jan 16, 2026 | Heyman Richard A. | Director | Sell (S) | 4K | $42K |
| Dec 16, 2025 | Multani Pratik S | Chief Medical Officer | Sell (S) | 11K | $97K |
| Dec 16, 2025 | Chacko Jacob | PRESIDENT AND CEO, Director | Sell (S) | 33K | $302K |
| Dec 16, 2025 | Piscitelli Dominic | Chief Financial Officer | Sell (S) | 11K | $97K |
| Oct 6, 2025 | Chacko Jacob | PRESIDENT AND CEO, Director | Sell (S) | 37K | $462K |
| Oct 6, 2025 | Piscitelli Dominic | Chief Financial Officer | Sell (S) | 11K | $160K |
Connected entities for ORIC
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ORIC/capital-change-brief"
Use Arkolith's capital_change_brief for ORIC. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ORIC. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.